Amphastar Pharmaceuticals Inc (AMPH) – Strategy, SWOT and Corporate Finance Report
- Pages: 49
- Published: June 2023
- Report Code: MLPH94919FSA
Amphastar Pharmaceuticals Inc (AMPH) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Amphastar Pharmaceuticals Inc (Amphastar), is a specialty pharmaceutical company that develops, manufactures, and markets generic and proprietary injectable, intranasal and inhalation products. It sells insulin-active pharmaceutical ingredient products. The company’s key products include enoxaparin sodium injection; cosyntropin for injection; naloxone hydrochloride (HCl) injection and phytonadione injection; lidocaine jelly; amphadase hyaluronidase injection; epinephrine, naloxone, phytonadione, primatene mist and glucagon. Amphastar offers its products to alternate care sites, hospitals, clinics and doctors’ offices and long-term care facilities. The company markets its products through subsidiaries, specialty distributors, wholesalers and retailers in the US, the UK, France and China. Amphastar is headquartered in Rancho Cucamonga, California, the US.
Scope
• Detailed information on Amphastar Pharmaceuticals Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Amphastar Pharmaceuticals Inc in the form of a SWOT analysis
• An in-depth view of the business model of Amphastar Pharmaceuticals Inc including a breakdown and examination of key business segments
• News about Amphastar Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Amphastar Pharmaceuticals Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Amphastar Pharmaceuticals Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Amphastar Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Apotex Corp
Akorn Operating Company LLC
Dr. Reddy's Laboratories Ltd
Fresenius Kabi USA LLC
Sagent Pharmaceuticals Inc
Hikma Pharmaceuticals USA Inc
Teva Pharmaceutical Industries Ltd
Nexus Pharmaceuticals Inc
Amneal Biosciences LLC
Cipla USA Inc
Sandoz Inc
Meitheal Pharmaceuticals Inc
OptiNose Inc
Sanofi
American Regent Inc
Eli Lilly and Co
Mylan Inc
Pfizer Inc
Mylan Inc
Pfizer Inc
Akorn Inc
Sanofi
American Regent Inc
OptiNose Inc
Meitheal Pharmaceuticals Inc
Nexus Pharmaceuticals Inc
Sagent Pharmaceuticals Inc
Fresenius Kabi USA LLC
Sandoz Inc
Teva Pharmaceutical Industries Ltd
Hikma Pharmaceuticals USA Inc
Cipla USA Inc
Amneal Biosciences LLC
Apotex Corp
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.